 |
인쇄하기
취소
|
Bi-nex patented a new therapy for lung and colon cancer.
Bi-nex announced on Oct. 12 that the company completed to register a process patent for a resin form of cell production for the immune therapy.
The company spent about 2 billion won worth of investment to develop this patent covering a cancer immune therapy by injecting a resin type of cells into the radiation exposed tumors, an electric perforation of tumor antigen and a cancer immune the...
The company spent about 2 billion won worth of investment to develop this patent covering a cancer immune therapy by injecting a resin type of cells into the radiation exposed tumors, an electric perforation of tumor antigen and a cancer immune the...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.